Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Related Citations for PubMed (Select 15566991)

1.

The imperative for family planning in ART therapy in Africa.

Shelton JD, Peterson EA.

Lancet. 2004 Nov 27-Dec 3;364(9449):1916-8. No abstract available.

PMID:
15566991
2.

HIV-infected women in ART programmes.

Myer L, Morroni C, Nachega J, Cooper D.

Lancet. 2005 Feb 19-25;365(9460):655-6. No abstract available.

PMID:
15721468
3.

The real challenges for scaling up ART in sub-Saharan Africa.

Van Damme W, Kober K, Laga M.

AIDS. 2006 Mar 21;20(5):653-6. No abstract available.

PMID:
16514294
4.

Will ART rollout in Africa drive an epidemic of drug resistant HIV?

Hastings IM, Lalloo D, Khoo SH.

AIDS. 2006 Jun 12;20(9):1354-6; author reply 1356-7. No abstract available.

PMID:
16816578
5.

Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.

Hastings IM, Lalloo DG, Khoo SH.

AIDS. 2007 Jan 11;21(2):258-9; author reply 259-60. No abstract available.

PMID:
17197825
6.

Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings.

Duerr A, Hurst S, Kourtis AP, Rutenberg N, Jamieson DJ.

Lancet. 2005 Jul 16-22;366(9481):261-3. No abstract available.

PMID:
16023518
7.

The obstetric face and challenge of HIV/AIDS.

Guidozzi F, Black V.

Clin Obstet Gynecol. 2009 Jun;52(2):270-84. doi: 10.1097/GRF.0b013e3181a4f365.

PMID:
19407534
8.

In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.

O'Brien DP, Sauvageot D, Zachariah R, Humblet P; Medecins Sans Frontieres.

AIDS. 2006 Oct 3;20(15):1955-60.

PMID:
16988517
9.

Antiretroviral treatment and the health workforce in South Africa: how have ART workers been affected by scaling up?

Tobi P, George G, Schmidt E, Renton A.

Trop Med Int Health. 2008 Dec;13(12):1452-8. doi: 10.1111/j.1365-3156.2008.02169.x. Epub 2008 Oct 29.

10.

Family planning choices for women with HIV.

Richey C, Setty V.

Popul Rep L. 2007 Aug;(15):1, 3-23. No abstract available.

PMID:
17974162
11.

Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa.

Rosen S, Sanne I, Collier A, Simon JL.

Lancet. 2005 Jan 22-28;365(9456):354-6. No abstract available.

PMID:
15664233
12.

[The challenges of preventing mother-to-child transmission of HIV in Africa].

Becquet R, Leroy V.

Presse Med. 2007 Dec;36(12 Pt 3):1947-57. Epub 2007 May 21. Review. French.

PMID:
17513081
13.

[HIV-infection].

Wasmuth JC, Rockstroh JK.

Dtsch Med Wochenschr. 2007 Mar 30;132(13):673-83; quiz 685-6. Review. German. No abstract available.

PMID:
17377882
14.

Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya.

Hawkins C, Achenbach C, Fryda W, Ngare D, Murphy R.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):304-10.

PMID:
17414931
15.

Preventing HIV transmission with antiretrovirals.

De Cock KM, Crowley SP, Lo YR, Granich RM, Williams BG.

Bull World Health Organ. 2009 Jul;87(7):488-488A. No abstract available.

16.

The obligation to provide antiretroviral treatment in HIV prevention trials.

Lo B, Padian N, Barnes M.

AIDS. 2007 Jun 19;21(10):1229-31.

PMID:
17545698
17.

Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.

Barker PM, McCannon CJ, Mehta N, Green C, Youngleson MS, Yarrow J, Bennett B, Berwick DM.

J Infect Dis. 2007 Dec 1;196 Suppl 3:S457-63. doi: 10.1086/521110. Review.

18.

Registration problems for antiretrovirals in Africa.

Ford N, Darder M.

Lancet. 2006 Mar 11;367(9513):794-5. No abstract available.

PMID:
16530559
19.

African trial of HIV drug disappoints.

[No authors listed]

AIDS Read. 2008 Apr;18(4):166. No abstract available.

PMID:
18467998
20.

Monitoring of antiretroviral therapy in low-resource settings.

Bendavid E.

Lancet. 2008 Jul 26;372(9635):288-9; author reply 289. doi: 10.1016/S0140-6736(08)61103-4. No abstract available.

PMID:
18657700
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk